Key result
The second-generation cryoballoon for pulmonary vein isolation resulted in a 2.8% rate of persistent phrenic nerve palsy compared to 1.9% with the first-generation balloon (P=0.63).
Why the study?
Does the second-generation cryoballoon alter the incidence and characteristics of phrenic nerve palsy compared to the first-generation cryoballoon in patients undergoing pulmonary vein isolation for atrial fibrillation?
Population
360 consecutive patients with atrial fibrillation undergoing pulmonary vein isolation
Comparison
Second-generation cryoballoon for pulmonary vein… vs First-generation cryoballoon for pulmonary vein…
Design
Cohort
Follow-up
Up to complete recovery of phrenic nerve function
Authors
Loading...
No difference in persistent phrenic nerve palsy rates; leaves open clinical relevance of longer recovery with second-generation devices.
Observational (n=360)
Does the second-generation cryoballoon alter the incidence and characteristics of phrenic nerve palsy compared to the first-generation cryoballoon in patients undergoing pulmonary vein isolation for atrial fibrillation?
Absolute Event Rate: 2.8% vs 1.9%
p-value: p=0.63
While the incidence of phrenic nerve palsy is similar between first- and second-generation cryoballoons, the second-generation device is associated with a significantly longer time to nerve function recovery.
Fürnkranz et al. (2015) conducted an observational in Atrial fibrillation (n=360). Second-generation cryoballoon (CB2) vs. First-generation cryoballoon (CB1) was evaluated on Persistent phrenic nerve palsy (present at discharge) (p=0.63). The second-generation cryoballoon for pulmonary vein isolation resulted in a 2.8% rate of persistent phrenic nerve palsy compared to 1.9% with the first-generation balloon (P=0.63).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: